Abstract:Post-stroke depression (PSD) is common consequence of stroke. However, the majority of PSD patients remains untreated or inadequately treated, especially in developing countries. In this systematic review and meta-analysis, our pooled results showed that hyperbaric oxygen therapy is an effective and safe therapeutic approach for PSD.Post-stroke depression (PSD) is common consequence of stroke. However, today the majority of PSD patients remains untreated or inadequately treated, especially in the developing countries. Herein, we performed a meta-analysis to evaluate efficacy and safety of hyperbaric oxygen (HBOT) therapy for PSD.Seven electronic databases were comprehensively searched for randomized clinical trials (RCTs) from inception to May 2019. Outcome measures included response rate, depression severity, neurological deficit, physical disability and adverse events.A total of 27 RCTs involving 2250 participants were identified. Patients in HBOT group had a higher response rate than patients in control group (response rate: 69.4% vs 51.2%, odds ratio [OR] = 2.51, 95% confidence interval [CI] [1.83–3.43], P = 0.000). HBOT significantly reduced Hamilton Depression (HAMD) –17 item scores (weighted mean difference [WMD] = −4.33, 95% CI [−4.82 to −3.84], P = 0.000), HAMD-24 item scores (WMD = −4.31, 95% CI [−5.01 to −3.62], P = 0.000), National Institute of Health Stroke Scale (NIHSS) scores (WMD = −2.77, 95% CI [−3.57 to −1.98], P = 0.000), Chinese Stroke Scale (CSS) scores (WMD = −3.75, 95% CI [−5.12 to −2.38], P = 0.000) and Modified Scandinavian Stroke Scale (MASSS) scores (WMD = −3.66, 95% CI [−6.26 to −1.06], P = 0.000). HBOT also improved Barthel Index (WMD = 10.68, 95% CI [7.98–13.37], P = 0.000). In subgroup analysis, Group A of studies with hemorrhage patients accounting for less than 20% achieved more reduction of HAMD 17-item score (WMD = −4.47, 95% CI [−5.17 to −3.77], P = 0.000) than Group B of studies with hemorrhage patients no less than 20% (WMD = −3.73, 95% CI [−4.20 to −3.26], P = 0.000). In addition, patents with HBOT along with antidepressants treatment achieve superior results than patients with antidepressants monotherapy. Patients with HBOT monotherapy achieve a slightly higher response rate than patients with antidepressants monotherapy (OR = 1.29, 95% CI [1.04–1.60], P = 0.000). Besides, HBOT group reported less adverse events (9.6%vs16.6%, P < 0.05). The most frequent side-effect of HBOT is ear pain (26 cases).Based on our pooled analysis, HBOT is effective and safe therapeutic approach for PSD. However, results should be cautiously interpreted due to a relatively poor methodological quality.

Efficacy and safety of hyperbaric oxygen therapy in acute ischaemic stroke: a systematic review and meta-analysis

The Efficacy of Hyperbaric Oxygen Therapy on Middle Cerebral Artery Occlusion in Animal Studies: A Meta-Analysis.

Hyperbaric Oxygen for Acute Ischemic Stroke:A Systematic Review of Randomized Controlled Trials

Hyperbaric Oxygen Therapy in Liver Diseases

Hyperbaric Oxygen Therapy In Experimental And Clinical Stroke

Efficacy And Safety Of Endovascular And Intravenous Therapy For Acute Ischemic Stroke: A Systematic Review And Network Meta Analysis

Efficacy and safety of mesenchymal stem cells in patients with acute ischemic stroke: a meta-analysis

Hyperbaric oxygen therapy for post-stroke depression: A systematic review and meta-analysis

Normobaric Hyperoxia Therapy in Acute Ischemic Stroke: A Literature Review

The Efficacy and Safety of Ischemic Stroke Therapies: An Umbrella Review

Efficacy and association of hyperbaric oxygen therapy combined with butylphthalide and oxiracetam with serum levels of inflammatory markers in vascular cognitive impairment after acute ischemic stroke

Hyperbaric Oxygen Therapy and Preconditioning for Ischemic and Hemorrhagic Stroke

Efficacy and Safety of Various Intravenous Thrombolytics for Acute Ischemic Stroke (AIS) at Various Dosages: A Systematic Review and Network Meta-Analysis

Efficacy and safety of Panax notoginseng saponins (Xuesaitong) for patients with acute ischemic stroke: a systematic review and meta-analysis of randomized controlled trials

Efficacy and safety of hyperbaric oxygen therapy for Parkinson's disease with cognitive dysfunction: protocol for a systematic review and meta-analysis

Efficacy and safety of hyperbaric oxygen therapy for long COVID: a protocol for systematic review and meta-analysis

Efficacy and safety of anisodine hydrobromide injection for acute ischemic stroke: a systematic review and meta-analysis

Efficacy and Safety of Traditional Chinese Medicine for Acute Ischemic Stroke by Resolving Phlegm and Unblocking Fu-Organs: A Systematic Review and Meta-Analysis.

Hyperbaric oxygen therapy for spinal cord injury A protocol for systematic review and meta-analysis

Efficacy and safety of normobaric hyperoxia combined with intravenous thrombolysis on acute ischemic stroke patients

Efficacy and safety of stem cells in the treatment of ischemic stroke: A meta-analysis